We’re always looking for ways to improve. If you’ve got feedback or suggestions about how we can do better, we’d love to hear from you.
Presents the newest thinking and data needed for clinicians to reduce atherosclerotic cardiovascular disease (ASCVD) risk. This book provides detailed evidence-based guidance for treating cholesterol to reduce ASCVD with a focus on recent ACC/AHA guidelines, an overview of evidence-based treatment of other risk factors, the management of genetic and acquired lipid disorders, and complete efficacy and safety information on all available lipid-lowering agents, including clinical trial data and FDA-approved labeling.
Professor of Epidemiology and Medicine, University of Iowa